Niagen Bioscience has expanded its NAD+ research program to investigators in more than 30 countries and into oral, topical, intravenous and injectable formats.

Niagen Bioscience has expanded its NAD+ research program to investigators in more than 30 countries and into oral, topical, intravenous and injectable formats. The move signals a broader push as NAD+ research raises new scientific questions.